Dr. Heather Wakelee from Stanford University presents her view on the most promising emerging targeted therapies and pathways for treating lung cancer in the coming years.
Dr. Heather Wakelee from Stanford University presents her view on the most promising emerging targeted therapies and pathways for treating lung cancer in the coming years.
read more
read less
10 years ago
#antiangiogenesis, #antipd1, #antipdl1, #biomarker, #cancergrace, #grace, #gracecast, #heather, #immunotherapy, #inhibitor, #mek, #met, #metmab, #onartuzumab, #selumetinib, #stanford, #targeted, #therapy, #university, #wakelee